BLU-667 : Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities

GSK’872: Ripk3-induced inflammation by I-MDSCs promotes intestinal tumors

Lurbinectedin : Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein